Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Oncology Institute Inc.

    NASDAQ: TOI · Real-Time Price · USD
    2.45
    -0.02 (-0.81%)
    At close: Jun 16, 2025, 3:59 PM

    Oncology Institute Statistics

    Share Statistics

    Oncology Institute has 89.19M shares outstanding. The number of shares has increased by 1.77% in one year.

    Shares Outstanding

    n/a
    		 89.19M

    Shares Change (YoY)

    n/a
    		 1.77%

    Shares Change (QoQ)

    n/a
    		 0.26%

    Owned by Institutions (%)

    n/a
    		 19.48%

    Shares Floating

    n/a
    		 40.96M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,021

    FTD / Avg. Volume

    n/a
    		 0.2%

    Short Selling Information

    The latest short interest is 1.56M, so 1.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.56M

    Short % of Shares Out

    n/a
    		 1.75%

    Short % of Float

    n/a
    		 2.16%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.36 and the forward PE ratio is -27.56. Oncology Institute's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.36

    Forward PE

    n/a
    		 -27.56

    PS Ratio

    n/a
    		 0.06

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 6.46

    P/FCF Ratio

    n/a
    		 -0.76

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Oncology Institute.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.15, with a Debt / Equity ratio of 34.31.

    Current Ratio

    n/a
    		 2.15

    Quick Ratio

    n/a
    		 1.96

    Debt / Equity

    n/a
    		 34.31

    Debt / EBITDA

    n/a
    		 -2.42

    Debt / FCF

    n/a
    		 -4.06

    Interest Coverage

    n/a
    		 -8.02

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $476,863.03

    Profits Per Employee

    n/a
    		 $-78,379.39

    Employee Count

    n/a
    		 825

    Asset Turnover

    n/a
    		 2.28

    Inventory Turnover

    n/a
    		 33.81

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 440.6% in the last 52 weeks. The beta is 0.16, so Oncology Institute's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.16

    52-Week Price Change

    n/a
    		 440.6%

    50-Day Moving Average

    n/a
    		 2.61

    200-Day Moving Average

    n/a
    		 1.02

    Relative Strength Index (RSI)

    n/a
    		 41.47

    Average Volume (20 Days)

    n/a
    		 1,529,825

    Income Statement

    In the last 12 months, Oncology Institute had revenue of 393.41M and earned -64.66M in profits. Earnings per share was 0.

    Revenue

    n/a
    		 393.41M

    Gross Profit

    n/a
    		 54M

    Operating Income

    n/a
    		 -60.12M

    Net Income

    n/a
    		 -64.66M

    EBITDA

    n/a
    		 -50.88M

    EBIT

    n/a
    		 -57.17M

    Earnings Per Share (EPS)

    n/a
    		 0
    Full Income Statement

    Balance Sheet

    The company has 49.67M in cash and 123.15M in debt, giving a net cash position of -73.48M.

    Cash & Cash Equivalents

    n/a
    		 49.67M

    Total Debt

    n/a
    		 123.15M

    Net Cash

    n/a
    		 -73.48M

    Retained Earnings

    n/a
    		 -210.81M

    Total Assets

    n/a
    		 164M

    Working Capital

    n/a
    		 47.28M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -26.54M and capital expenditures -3.79M, giving a free cash flow of -30.33M.

    Operating Cash Flow

    n/a
    		 -26.54M

    Capital Expenditures

    n/a
    		 -3.79M

    Free Cash Flow

    n/a
    		 -30.33M

    FCF Per Share

    n/a
    		 -0.4
    Full Cash Flow Statement

    Margins

    Gross margin is 13.73%, with operating and profit margins of -15.28% and -16.44%.

    Gross Margin

    n/a
    		 13.73%

    Operating Margin

    n/a
    		 -15.28%

    Pretax Margin

    n/a
    		 -16.44%

    Profit Margin

    n/a
    		 -16.44%

    EBITDA Margin

    n/a
    		 -12.93%

    EBIT Margin

    n/a
    		 -15.28%

    FCF Margin

    n/a
    		 -7.71%

    Dividends & Yields

    TOI does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TOI is $2.5, which is 2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $2.5

    Price Target Difference

    n/a
    		 2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.87

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist